Skip to content
Moojaz — موجز
Search
Menu
HomeRegionsMaghrebAfricaMiddle EastEuropeAsiaAmericasWorldSectionsPoliticsEconomySecurityHealthScienceTechnologyAIEnvironmentCultureSportsSearch
United Arab Emirates
File

UAE: reporting medicine side effects

This dossier follows UAE pharmacovigilance campaigns and their reporting and assessment mechanisms.

Last updated : 1 key moments
Stethoscope on a white background.
Generic medical illustration from 2014; it does not depict the study or campaign. Sprinno, CC0. — Sprinno / Wikimedia Commons — CC0 1.0 https://creativecommons.org/publicdomain/zero/1.0/ — 28 février 2014, sans modification.

Where things stand

The Emirates Drug Establishment announced a campaign on 4 November 2026 urging patients, caregivers and professionals to report suspected medicine side effects, Khaleej Times reports. It forms part of MedSafetyWeek, running from 2 to 8 November.

Reported information

UAE campaign urges reporting of suspected medicine side effects

The Emirates Drug Establishment announced a campaign on 4 November 2026 urging patients, caregivers and professionals to report suspected medicine side effects, Khaleej Times reports. It forms part of MedSafetyWeek, running from 2 to 8 November.

Stethoscope on a white background.
Generic medical illustration from 2014; it does not depict the study or campaign. Sprinno, CC0. — Sprinno / Wikimedia Commons — CC0 1.0 https://creativecommons.org/publicdomain/zero/1.0/ — 28 février 2014, sans modification.

The “Speak Up .. Stay Safe” campaign brings five health authorities together with the federal establishment. EDE DAWA is presented as a channel for forwarding reports to specialists for assessment.

Virtual workshops for healthcare staff, University of Sharjah activities and a webinar for pharmaceutical companies are planned. The campaign concerns monitoring after medicines enter the market: a report describes a suspicion and does not, by itself, establish that a medicine caused a symptom.

Sources 2